Jump to:
Micardis (telmisartan) can now be prescribed for the prevention of cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke or peripheral arterial disease), or type 2 diabetes with documented target organ damage.
The recommended dose for this indication is 80mg once daily.
Further information: Boehringer Ingelheim
There are currently no comments.
You must log in to comment on articles.
New users can register here free for full access.
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
A Haymarket Publication © 1957 – 2010
